Mercator Medical SA (MM2) Ratios
Mercator Medical SA Ratios
DE:MM2's free cash flow for Q2 2026 was $-29.05M. For the 2026 fiscal year, DE:MM2's free cash flow was decreased by $-7.95M and operating cash flow was $-21.10M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.09 | 6.55 | 7.46 | 11.63 | 6.87 |
| Quick Ratio | 3.12 | 4.34 | 5.51 | 8.22 | 4.97 |
| Cash Ratio | 1.44 | 1.27 | 2.77 | 3.73 | 2.55 |
| Solvency Ratio | 0.45 | 0.59 | 0.02 | -2.22 | 3.25 |
| Operating Cash Flow Ratio | 0.62 | -0.74 | -0.00 | 0.68 | 3.78 |
| Short-Term Operating Cash Flow Coverage | 12.35 | -1470.53 | -0.58 | 193.33 | 385.15 |
| Net Current Asset Value | $ 370.77M | $ 516.39M | $ 479.72M | $ 623.71M | $ 770.86M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | 0.00 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.12 | 1.12 | 1.07 | 1.13 |
| Debt Service Coverage Ratio | 2.83 | 7.12 | -71.88 | -162.85 | 251.06 |
| Interest Coverage Ratio | -23.77 | 76.05 | -104.71 | -227.09 | 850.34 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.56 | 0.53 | 0.65 | 0.43 | 0.53 |
| Net Debt to EBITDA | -8.10 | 25.18 | 4.12 | 1.38 | -0.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.09% | 26.00% | 21.92% | 16.28% | 39.59% |
| EBIT Margin | -2.48% | -4.33% | -15.67% | -34.26% | 27.63% |
| EBITDA Margin | 2.54% | -0.87% | -10.96% | -29.45% | 28.78% |
| Operating Profit Margin | -2.48% | 5.73% | -18.57% | -33.40% | 26.83% |
| Pretax Profit Margin | 4.95% | 7.71% | -0.81% | -34.32% | 27.63% |
| Net Profit Margin | 4.98% | 9.41% | -4.19% | -34.95% | 25.87% |
| Continuous Operations Profit Margin | 5.11% | 9.18% | -4.87% | -35.17% | 25.75% |
| Net Income Per EBT | 100.68% | 121.94% | 518.88% | 101.83% | 93.64% |
| EBT Per EBIT | -199.79% | 134.59% | 4.35% | 102.76% | 102.98% |
| Return on Assets (ROA) | 2.78% | 4.89% | -2.04% | -17.51% | 34.68% |
| Return on Equity (ROE) | 3.16% | 5.50% | -2.28% | -18.80% | 39.07% |
| Return on Capital Employed (ROCE) | -1.53% | 3.29% | -9.82% | -17.71% | 40.11% |
| Return on Invested Capital (ROIC) | -1.52% | 3.28% | -9.81% | -17.70% | 37.30% |
| Return on Tangible Assets | 2.85% | 5.05% | -2.11% | -17.92% | 34.94% |
| Earnings Yield | 8.18% | 11.37% | -4.95% | -39.33% | 45.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.71 | 5.91 | 4.51 | 7.79 | 13.86 |
| Payables Turnover | 7.18 | 5.20 | 8.34 | 12.69 | 18.27 |
| Inventory Turnover | 2.40 | 1.87 | 2.91 | 2.22 | 4.12 |
| Fixed Asset Turnover | 1.67 | 1.75 | 1.84 | 1.90 | 5.14 |
| Asset Turnover | 0.56 | 0.52 | 0.49 | 0.50 | 1.34 |
| Working Capital Turnover Ratio | 1.22 | 1.04 | 0.82 | 0.76 | 2.11 |
| Cash Conversion Cycle | 165.20 | 186.63 | 162.66 | 182.55 | 94.97 |
| Days of Sales Outstanding | 63.91 | 61.78 | 80.99 | 46.83 | 26.33 |
| Days of Inventory Outstanding | 152.10 | 195.09 | 125.45 | 164.47 | 88.62 |
| Days of Payables Outstanding | 50.81 | 70.25 | 43.79 | 28.75 | 19.98 |
| Operating Cycle | 216.01 | 256.87 | 206.44 | 211.30 | 114.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.54 | -7.67 | -0.01 | 4.18 | 49.69 |
| Free Cash Flow Per Share | 1.01 | -9.67 | -4.09 | -7.05 | 32.23 |
| Dividend Paid and CapEx Coverage Ratio | 0.87 | -3.85 | -0.00 | 0.37 | 2.85 |
| Capital Expenditure Coverage Ratio | 1.18 | -3.85 | -0.00 | 0.37 | 2.85 |
| Operating Cash Flow Coverage Ratio | 2.62 | -15.79 | -0.02 | 12.03 | 104.14 |
| Operating Cash Flow to Sales Ratio | 0.11 | -0.13 | -0.00 | 0.08 | 0.29 |
| Free Cash Flow Yield | 2.68% | -20.23% | -9.84% | -14.28% | 33.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.23 | 8.79 | -20.21 | -2.54 | 2.20 |
| Price-to-Sales (P/S) Ratio | 0.61 | 0.83 | 0.85 | 0.89 | 0.57 |
| Price-to-Book (P/B) Ratio | 0.39 | 0.48 | 0.46 | 0.48 | 0.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 37.36 | -4.94 | -10.16 | -7.00 | 3.01 |
| Price-to-Operating Cash Flow Ratio | 5.80 | -6.23 | -4624.71 | 11.82 | 1.95 |
| Price-to-Earnings Growth (PEG) Ratio | -0.28 | -0.02 | 0.23 | 0.02 | -0.04 |
| Enterprise Value Multiple | 15.90 | -70.13 | -3.61 | -1.64 | 1.30 |
| Enterprise Value | 231.53M | 330.24M | 185.81M | 262.22M | 647.04M |
| EV to EBITDA | 15.90 | -70.13 | -3.61 | -1.64 | 1.30 |
| EV to Sales | 0.40 | 0.61 | 0.40 | 0.48 | 0.37 |
| EV to Free Cash Flow | 24.75 | -3.64 | -4.75 | -3.81 | 1.98 |
| EV to Operating Cash Flow | 3.84 | -4.58 | -2160.53 | 6.43 | 1.29 |
| Tangible Book Value Per Share | 94.74 | 95.15 | 86.25 | 100.75 | 112.19 |
| Shareholders’ Equity Per Share | 98.07 | 98.87 | 89.95 | 103.24 | 113.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | -0.19 | -5.02 | -0.02 | 0.07 |
| Revenue Per Share | 62.27 | 57.80 | 48.94 | 55.53 | 170.66 |
| Net Income Per Share | 3.10 | 5.44 | -2.05 | -19.41 | 44.15 |
| Tax Burden | 1.01 | 1.22 | 5.19 | 1.02 | 0.94 |
| Interest Burden | -2.00 | -1.78 | 0.05 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.21 | 0.24 | 0.00 | 0.11 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.11 | -1.41 | 0.00 | -0.22 | 1.13 |
Currency in PLN
